Health Condition 1: A419- Sepsis, unspecified organism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Critically ill patients with sepsis and septic shock, mechanically ventilated patients with iatrogenic volume overload requiring de-resuscitation. Volume overload will be identified by cumulative positive fluid balance of more than 10 percent body weight and / or by clinical signs of fluid overload like in lungs (chest Xray, lung ultrasound ), venous excess ultrasound grade more than 0, of will be included.
Exclusion criteria
Exclusion criteria: 1. Refusal to participate 2. Pregnancy or post- partum up to 6 weeks 3. Patients who are requiring vasopressor/ inotrope more than norepinephrine dose of 0.2 micrograms per kg per min or equivalent doses. 4. Hypernatremia more than 155 meq/L 5. Receiving renal replacement therapy 6. Patients with medical conditions like diabetic ketoacidosis, hyperosmolar hyperglycemic states, nontraumatic subarachnoid hemorrhage. 7. Acute cardiogenic shock 8. Known allergy to the drugs used
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to compare serum hyaluronan level before and after ?protocolized de-resuscitation? in critically ill mechanically ventilated adult patients with iatrogenic volume overloadTimepoint: Day 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare syndecan-1, VE- Cadherin, bio- adrenomedullin and heparan sulphate level before and after ?protocolized de-resuscitation?. 2. To compare ESR & C- reactive protein level before and after ?protocolized de-resuscitation?. 3. To compare serum albumin level before and after ?protocolized deresuscitation?. 4. To compare serum urea and creatine before and after ?protocolized deresuscitation?. 5. To know the association between change in glycocalyx degradation product and intensive care unit stay since recruitment in this study. 6. To know the association between change in glycocalyx degradation product and negative fluid balance since recruitment in this study. Timepoint: Day 3; 7. To know the association between change in glycocalyx degradation product and survival to ICU dischargeTimepoint: Upto day 30 | — |
Countries
India
Contacts
AIIMS, New Delhi